Literature DB >> 27189383

A qualitative study exploring visible components of organizational culture: what influences the use of psychotropic medicines in nursing homes?

Mouna J Sawan1, Yun-Hee Jeon2, Romano J Fois1, Timothy F Chen1.   

Abstract

BACKGROUND: The influence of organizational culture on how psychotropic medicines are used in nursing homes has not been extensively studied. Schein's theory provides a framework for examining organizational culture which begins with the exploration of visible components of an organization such as behaviors, structures, and processes. This study aimed to identify key visible components related to the use of psychotropic medicines in nursing homes.
METHODS: A qualitative study was conducted in eight nursing homes in Sydney, Australia. Purposive sampling was used to conduct semi-structured interviews with 40 participants representing a broad range of health disciplines. Thematic analysis was used to derive concepts.
RESULTS: Three visible components were related to psychotropic medicine use. These were drugs and therapeutics committee meetings, pharmacist led medication management reviews and formal and informal meetings with residents and their families. We found that only a few nursing homes utilized drugs and therapeutics committee meetings to address the overuse of psychotropic medicines. Pharmacist led medication management reviews provided a lever to minimize inappropriate psychotropic prescribing for a number of nursing homes; however, in others it was used as a box-ticking exercise. We also found that some nursing homes used meetings with residents and their families to review the use of psychotropic medicines.
CONCLUSION: This study was the first to illustrate that visible components of organizational culture do influence the use of psychotropic medicines and explains in detail what of the culture needs to be addressed to reduce inappropriate psychotropic prescribing.

Entities:  

Keywords:  antipsychotics; long-term care; nursing homes; organizational culture; patient safety; psychotropic medications; qualitative

Mesh:

Substances:

Year:  2016        PMID: 27189383     DOI: 10.1017/S1041610216000715

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  6 in total

Review 1.  Approaches to Deprescribing Psychotropic Medications for Changed Behaviours in Long-Term Care Residents Living with Dementia.

Authors:  Stephanie L Harrison; Monica Cations; Tiffany Jessop; Sarah N Hilmer; Mouna Sawan; Henry Brodaty
Journal:  Drugs Aging       Date:  2019-02       Impact factor: 3.923

Review 2.  Relationship between Organizational Culture and the Use of Psychotropic Medicines in Nursing Homes: A Systematic Integrative Review.

Authors:  Mouna Sawan; Yun-Hee Jeon; Timothy F Chen
Journal:  Drugs Aging       Date:  2018-03       Impact factor: 3.923

Review 3.  A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review.

Authors:  Mouna Sawan; Emily Reeve; Justin Turner; Adam Todd; Michael A Steinman; Mirko Petrovic; Danijela Gnjidic
Journal:  Expert Rev Clin Pharmacol       Date:  2020-02-27       Impact factor: 5.045

4.  How do healthcare professionals make decisions concerning low-value care practices? Study protocol of a factorial survey experiment on de-implementation.

Authors:  Marta Roczniewska; Ulrica von Thiele Schwarz; Hanna Augustsson; Per Nilsen; Sara Ingvarsson; Henna Hasson
Journal:  Implement Sci Commun       Date:  2021-05-19

Review 5.  Determinants for the use and de-implementation of low-value care in health care: a scoping review.

Authors:  Hanna Augustsson; Sara Ingvarsson; Per Nilsen; Ulrica von Thiele Schwarz; Irene Muli; Jessica Dervish; Henna Hasson
Journal:  Implement Sci Commun       Date:  2021-02-04

6.  What Makes Deprescription of Psychotropic Drugs in Nursing Home Residents with Dementia so Challenging? A Qualitative Systematic Review of Barriers and Facilitators.

Authors:  Amalie Elisabeth Moth; Pernille Hølmkjær; Anne Holm; Maarten Pieter Rozing; Gritt Overbeck
Journal:  Drugs Aging       Date:  2021-07-07       Impact factor: 3.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.